Synageva BioPharma Corp. (NASDAQ: GEVA)

Matthew Osborne

Vice President, Investor Relations &
Corporate Communications

Synageva BioPharma Corp.
33 Hayden Avenue
Lexington, MA 02421
Phone: 781-357-9947
Fax: 781-357-9901

Please submit your question using the form below.

* Indicates required field